SCHEMBL2056449

SCHEMBL2056449

CCOP(=O)(CN(c1c(-c2ccccc2)ccc2ccccc12)S(=O)(=O)c1cc(Cl)cc(Cl)c1)OCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.37
S1PR1 P21453 1/20 0.36
KEAP1 Q14145 3/20 0.35
NFE2L2 Q16236 3/20 0.35
HTR1A P08908 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR7 P34969 1/20 0.32
DRD3 P35462 1/20 0.32
HTR6 P50406 1/20 0.32
NR1I2 O75469 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
C1R P00736 1/20 0.32
PRSS1 P07477 1/20 0.32
PTGS2 P35354 1/20 0.30
GBA1 P04062 1/20 0.30
ESR1 P03372 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2055381 0.88 S1PR1 (0.37) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL2055365 0.87 S1PR1 (0.36) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL2055386 0.87 S1PR1 (0.36) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL13905585 0.86 S1PR1 (0.35) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL2055389 0.85 MAPT (0.35) ACLYS1PR1KDM4EMEN1KMT2A
SCHEMBL2056457 0.85 ACLY (0.40) ACLYS1PR1KEAP1NFE2L2
SCHEMBL2055358 0.84 MAPT (0.32) S1PR1KDM4EC1RPRSS1
SCHEMBL2055462 0.84 S1PR1 (0.34) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL2055382 0.84 MAPT (0.34) S1PR1HTR1AHTR2AHTR2CHTR7
SCHEMBL2055397 0.83 UTRN (0.37) KDM4EHPGDC1RPRSS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163911-B2 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-24 US disclosed
US-20100261677-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261677-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS ARSA, SULT2A1, PMM2 ACLY 633/4885S1PR1 148/4885KEAP1 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.